Filing Details

Accession Number:
0001493152-19-008727
Form Type:
13G Filing
Publication Date:
2019-06-05 15:38:36
Filed By:
Emerson John Steven
Company:
Emmaus Life Sciences Inc. (OTCMKTS:EMMA)
Filing Date:
2019-06-05
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
John Steven Emerson 694,121 0 694,121 0 694,121 5.46%
Filing

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

 

(Amendment No.      )*

 

MYnd Analytics, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

62857N202

(CUSIP Number)

 

May 28, 2019

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[  ]: Rule 13d-1(b)

 

[X]: Rule 13d-1(c)

 

[  ]: Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

1

NAME OF REPORTING PERSON OR

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

John Steven Emerson

 
2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a) [  ]

(b) [  ]

3

SEC USE ONLY

 

 
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

USA

 

NUMBER OF

SHARES

BENEFICIALLY OWNED

BY EACH REPORTING

PERSON

WITH

5

SOLE VOTING POWER

 

694,121*

6

SHARED VOTING POWER

 

-0-

7

SOLE DISPOSITIVE POWER

 

694,121*

8

SHARED DISPOSITIVE POWER

 

-0-

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

694,121*

 
10

CHECK BCHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

[  ]
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

5.46%

 
12

TYPE OF REPORTING PERSON

 

IN

 

 

* Represents the aggregate of 659,415 shares held by J. Steven Emerson Roth IRA and 34,706 shares held by Emerson Partners. Reporting person has voting and dispositive power over the shares held by these entities.

 

 

 

ITEM 1  

 

(a) Name of Issuer
   
  MYnd Analytics, Inc. (the “Issuer”)

 

(b) Address of Issuer’s Principal Executive Offices
   
  26522 La Alameda
  Mission Viejo, CA 92691

 

ITEM 2  

 

(a) Names of Persons Filing
   
  John Steven Emerson

 

(b) Address of Principal Business Office or, if none, Residence
   
  1522 Ensley Avenue
  Los Angeles, CA 90024

 

(c) Citizenship
   
  USA

 

(d) Title of Class of Securities
   
  Common Stock

 

(e) CUSIP Number
   
  62857N202

 

ITEM 3 If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
   
  Not applicable.

 

 

 

ITEM 4 Ownership
   
  Ownership information is incorporated by reference through items (5) through (9) and (11) of the cover page.

 

ITEM 5 Ownership of Five Percent or Less of a Class
   
  Not applicable.

 

ITEM 6 Ownership of More than Five Percent on Behalf of Another Person
   
  Not applicable.

 

ITEM 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
   
  Not applicable.

 

ITEM 8 Identification and Classification of Members of the Group
   
  Not applicable.

 

ITEM 9 Notice of Dissolution of Group
   
  Not applicable.

 

 

 

ITEM 10 Certifications

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  June 5, 2019
   
  /s/ John Steven Emerson
  John Steven Emerson